ADVANCES IN FIGHTING INFECTION
Molecular Testing for
New clinical data around chronic wounds show that certain pathogens damage DNA prohibiting wound healing. Additionally 90% of chronic wounds show evident of biofilm compared to 6% of acute wounds. Biofilms have a high resistance to antibiotics and proper detection is critical to proper wound management.
HEALIX Medical Solutions is a division of National Wound Care that provides rapid and accurate detection of infection with antibiotic guidance. Infectious disease panels include Wound, Respiratory, UTI, GI, STD, and Women's Health.
Studies have shown that the Traditional Culture Method developed over 75 years ago is substandard to identifying infections. NWC uses molecular technology through Real-Time PCR detection to identify pathogens at 98% accuracy.
Learn More >
PCR VS. TRADITIONAL CULTURE
Reasons to Consider Using
Molecular Lab Results for Wound Care
Identifies microbial RNA/DNA with 98% accuracy.
Results within returned within 24 hours.
Wider range of pathogens and microbes identified simultaneously.
Analysis NOT affected by current antibiotics used by patient.
Trial and error leading up to 60% false negative results.
Results ranging from 3-7 days.
Inconclusive results due to "contaminated" samples if more than 3 microbes identified AND certain microbes do not grow outside the host.
Antibiotic use affects outcome of analysis.
INFECTIOUS DISEASE PANELS
Our Specialty PCR
Lab Tests Include
NWC implemented molecular testing because of its efficacy for wound pathogens and biofilm. Due to the superior uses for other major infections and chronic illness, we have implemented the following panels into our programs.
COVID-19 results are included in our respiratory infectious disease lab collection kits. These are covered under Medicare and most insurance. For Facility staff screening, tests are $100 or per your contract with NWC.